v3.26.3
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
May 2025 Public Offering
Previously Reported
Common Class H
Common Class I
Common Stock
Common Stock
Rollover RSU Award
Common Stock
Restricted Stock Units (RSUs) [Member]
Common Stock
May 2025 Public Offering
Common Stock
Previously Reported
Common Stock
Common Class F
Common Stock
Common Class H
Common Stock
Common Class I
Additional Paid-in Capital
Additional Paid-in Capital
Restricted Stock Units (RSUs) [Member]
Additional Paid-in Capital
May 2025 Public Offering
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Common Class F
Additional Paid-in Capital
Common Class H
Additional Paid-in Capital
Common Class I
Accumulated Deficit
Accumulated Deficit
Previously Reported
Retrospective application of reverse recapitalization           $ (38)               $ 38                
Retrospective application of reverse recapitalization, Shares           (37,308)                                
Reverse stock split fractional stock round up (in Shares)           35                                
Balance at Dec. 31, 2024 $ 4,708,382   $ 4,708,382     $ 6       $ 44       45,214,014     $ 45,213,976       $ (40,505,638) $ (40,505,638)
Balance (in Shares) at Dec. 31, 2024           6,253       43,526                        
Alternative cashless exercise of common stock warrants                     $ 5             $ (5)        
Alternative cashless exercise of common stock warrants (in Shares)                     4,560                      
Issuance of RSA's           $ 1               (1)                
Issuance of RSA's, Shares           699                                
Stock-based compensation expense 223,455                         223,455                
Net Loss (2,051,085)                                       (2,051,085)  
Balance at Mar. 31, 2025 2,880,752         $ 12               45,437,463             (42,556,723)  
Balance (in Shares) at Mar. 31, 2025           11,512                                
Balance at Dec. 31, 2024 4,708,382   4,708,382     $ 6       $ 44       45,214,014     45,213,976       (40,505,638) (40,505,638)
Balance (in Shares) at Dec. 31, 2024           6,253       43,526                        
Net Loss (6,402,643)                                          
Balance at Sep. 30, 2025 11,001,835         $ 128               57,909,988             (46,908,281)  
Balance (in Shares) at Sep. 30, 2025           128,111                                
Balance at Mar. 31, 2025 2,880,752         $ 12               45,437,463             (42,556,723)  
Balance (in Shares) at Mar. 31, 2025           11,512                                
Issuance of common stock   $ 3,388,244             $ 8             $ 3,388,236            
Issuance of common stock (Shares)                 8,036                          
Pre-Funded Warrants Exercises       $ 297               $ 35             $ 262      
Pre-Funded Warrants Exercises (in Shares)                       35,298                    
Issuance of RSA's, Shares             1                              
Stock-based compensation expense 873                         873                
Net Loss (2,444,382)                                       (2,444,382)  
Balance at Jun. 30, 2025 3,825,784         $ 55               48,826,834             (45,001,105)  
Balance (in Shares) at Jun. 30, 2025           54,847                                
Alternative cashless exercise of common stock warrants                     $ 1             $ (1)        
Alternative cashless exercise of common stock warrants (in Shares)                     1,489                      
Issuance of RSA's, Shares             1                              
Common Stock Warrants exercises 363,000         $ 6               362,994                
Common Stock Warrants exercises, Shares           5,893                                
Warrant Inducement exercises 8,719,353         $ 66               8,719,287                
Warrant Inducement exercises, Shares           65,881                                
Stock-based compensation expense 874                         874                
Net Loss (1,907,176)                                       (1,907,176)  
Balance at Sep. 30, 2025 11,001,835         $ 128               57,909,988             (46,908,281)  
Balance (in Shares) at Sep. 30, 2025           128,111                                
Retrospective application of reverse recapitalization           $ (1,358)               1,358                
Retrospective application of reverse recapitalization, Shares           (1,357,687)                                
Reverse stock split fractional stock round up (in Shares)           48                                
Balance at Dec. 31, 2025 8,860,995   8,860,995     $ 226       $ 1,584       58,280,056     58,278,698       (49,419,287) (49,419,287)
Balance (in Shares) at Dec. 31, 2025           226,330       1,583,969                        
Shares released from abeyance           $ 27               (27)                
Shares released from abeyance, Shares           26,881                                
Warrant Inducement exercises         $ 6,666,012               $ 305             $ 6,665,707    
Warrant Inducement exercises, Shares                         305,180                  
Stock-based compensation expense 470,997                         470,997                
Net Loss (3,009,051)                                       (3,009,051)  
Balance at Mar. 31, 2026 12,988,953         $ 558               65,416,733             (52,428,338)  
Balance (in Shares) at Mar. 31, 2026           558,391                                
Balance at Dec. 31, 2025 8,860,995   $ 8,860,995     $ 226       $ 1,584       58,280,056     $ 58,278,698       (49,419,287) $ (49,419,287)
Balance (in Shares) at Dec. 31, 2025           226,330       1,583,969                        
Net Loss (9,647,948)                                          
Balance at Sep. 30, 2026 7,233,702         $ 683               66,300,254             (59,067,235)  
Balance (in Shares) at Sep. 30, 2026           683,442                                
Balance at Mar. 31, 2026 12,988,953         $ 558               65,416,733             (52,428,338)  
Balance (in Shares) at Mar. 31, 2026           558,391                                
Stock-based compensation expense 401,417                         401,417                
Net Loss (3,323,384)                                       (3,323,384)  
Balance at Jun. 30, 2026 10,066,986         $ 558               65,818,150             (55,751,722)  
Balance (in Shares) at Jun. 30, 2026           558,391                                
Issuance of RSA's           $ 114   $ 11           (114) $ (11)              
Issuance of RSA's, Shares           114,333   10,718                            
Stock-based compensation expense 482,229                         482,229                
Net Loss (3,315,513)                                       (3,315,513)  
Balance at Sep. 30, 2026 $ 7,233,702         $ 683               $ 66,300,254             $ (59,067,235)  
Balance (in Shares) at Sep. 30, 2026           683,442